• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Australia cancels Lockheed Martin military satellite project

by November 4, 2024
written by November 4, 2024

SYDNEY (Reuters) – Australia has cancelled a multi-billion dollar military satellite project with Lockheed Martin (NYSE:LMT), with a Department of Defence statement on Monday saying the military will instead shift its focus to a multi-orbit system.

Lockheed Martin Australia was announced as the preferred tenderer last year for the Geostationary Earth Orbit (GEO) satellite communications system, in a project that was to deliver Australia’s first sovereign-controlled satellite communication system over the Indo-Pacific ocean regions.

The project for a single orbit satellite with Lockheed Martin had been cancelled, the Department of Defence said in a statement on Monday.

“With the acceleration in space technologies and evolving threats in space since the project’s commencement, Defence has assessed that a single orbit GEO-based satellite communications system would not meet strategic priorities,” the statement said.

It said Australia would instead prioritise a multi-orbit capability to increase resilience for the Australian Defence Force.

In a radio interview with the Australian Broadcasting Corporation, Prime Minister Anthony Albanese said while Australia’s defence budget was increasing, his government was prioritising its purchases.

When the Lockheed Martin project was announced last year it was said by authorities to be a “multi billion dollar” deal, but in Monday’s Defence statement there was no specific value to the cancelled project.

However, Defence said in the statement that it will still allocate A$9-12 billion ($13.87 billion) for space capabilities.

($1 = 1.5135 Australian dollars)

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Asia stocks rise with China stimulus, US elections in focus
next post
Australian police search Sydney PwC office over tax leak probe

You may also like

Adani, Ambani news units sue OpenAI over copyright,...

March 13, 2026

China’s DeepSeek sets off AI market rout

March 13, 2026

BASF results down on impairments, restructuring

March 13, 2026

Nasdaq futures tumble as China’s AI push rattles...

March 13, 2026

European chipmakers slump as traders gauge DeepSeek AI...

March 13, 2026

Fuji Media, rocked by sexual misconduct allegations, says...

March 13, 2026

China Vanke’s CEO, chairman resign amid growing liquidity...

March 13, 2026

Italy’s MPS shares fall ahead of Mediobanca board...

March 13, 2026

UMG shares rally after new multi-year pact with...

March 13, 2026

British Land stock drops following stake sale

March 13, 2026
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Trump administration alleges Nike discriminated against white workers

      March 13, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      March 13, 2026
    • Retail operator of outdoor sportswear pioneer Eddie Bauer files for bankruptcy

      March 13, 2026
    • Cardi B’s cameo in Bad Bunny’s Super Bowl halftime show leads to dispute on prediction markets

      March 13, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (690)
    • Stock (6,426)

    Latest News

    • Trump administration alleges Nike discriminated against white workers
    • Landmark trial accusing social media companies of addicting children to their platforms begins

    Popular News

    • Amazon’s Nova AI agent launch puts it up against rivals OpenAI, Anthropic
    • Earnings call: Castle Biosciences reports robust Q3 growth, raises guidance

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy